MedTrace Logo

Supporting Patient Care With Electronic Resource (SuPER)

NCT02540044 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2017-06-29

No results posted yet for this study

Summary

This proof-of-concept randomized trial evaluates the effectiveness of using an on-line decision aid (ANSWER-2) in the decision making to start or switch biologic therapy in Canadian patients with rheumatoid arthritis.

Conditions

  • Arthritis, Rheumatoid

Interventions

BEHAVIORAL

ANSWER-2 decision aid

ANSWER-2 will consist of: 1) an Information Module that presents effectiveness and side effects of each treatment option, and 2) an interactive Value Clarification Module that guides patients to consider what matter to them the most, and the pros and cons of each treatment option. Within the Information Module, the decision support information (i.e., the benefits and harms of treatment options) will be presented in narrated text, graphics, and a series of animated patient stories demonstrating attributes required for effective communication with doctors and significant others.

BEHAVIORAL

Control Group (TAS Consumer Guide)

The Arthritis Society Consumer guide pdf.

Sponsors & Collaborators

  • University of Alberta

    collaborator OTHER

  • Simon Fraser University

    collaborator OTHER

  • Arthritis Research Centre of Canada

    collaborator OTHER

  • Vancouver General Hospital

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Linda Li, PhD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02540044 on ClinicalTrials.gov